The Insides News- The Insides Neo - fistuloclysis, distal feeding, best, alternative to parenteral nutrition, fistula, ostomy, ileostomy, chyme, enteral, oral nutrition, enteromate, intestinal failure, colon cancer, bowel cancer, gut cancer, ostomy appliance, high output, chyme, dehydration, defunctioned, ileus, lars, microbiome, lower interior resection syndrome, incontinent, incontinence, gut health, reversal surgery
The Insides Company Announces the Launch of The Insides Driver Version Four (v4)

The Insides Company Announces the Launch of The Insides Driver Version Four (v4)

December 18, 2023

Source:The Insides Company Limited

On:18 December 2023

Organisation:The Insides Company Limited

The Insides System V4

The Insides Company is pleased to announce it has released version four (v4) of The Insides Driver. This new Driver contains added charging protection and a longer battery life of up to four weeks between recharges. The new version of The Insides Driver is identifiable by the purple front label. All previous versions had a white front label.

The Insides Company's purpose is to revolutionise the treatment of all patients who have suffered an intestinal catastrophe. The Insides System is a purpose-built medical device for performing chyme reinfusion therapy. Chyme reinfusion is a practice in the management of patients with high-output enterocutaneous fistulas, and high-output enterostomies. It enables patients to re-commence oral feeding, resulting in significant clinical benefits, health economic benefits, and improvements in patient quality of life.

About The Insides Company

The Insides Company Limited is a leading provider of automated chyme reinfusion solutions for the therapeutic treatment of intestinal failure that has resulted from either a high-output enterocutaneous fistula or enterostomy.


The Insides Company

Garth Sutherland

Phone:+64 9 887 9309

Choose Your Language

Selecting language below will change the language for